Lee S. Simon

Rheumatology

110 Francis St Ste 4B
Boston, MA 02215

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: a key concept in clinical epidemiology.

Harm outcomes applicable for most meta-analyses of randomized trials of biomedical interventions: a key concept in clinical epidemiology.

Journal: Journal of clinical epidemiology

Published: January 28, 2026

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Validity and utility of a single-item patient-reported measure of treatment-related bother in rheumatoid arthritis: A cross-sectional OMERACT study.

Journal: Seminars in arthritis and rheumatism

Published: November 19, 2025

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinement.

Journal: Seminars in arthritis and rheumatism

Published: October 15, 2025

The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative.

The complexity of pain in inflammatory arthropathies beyond pain intensity and impact: An OMERACT initiative.

Journal: Seminars in arthritis and rheumatism

Published: September 08, 2025

Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.

Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study.

Journal: Lupus science & medicine

Published: December 19, 2024

Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Slow acting medications for progressive and painful knee osteoarthritis. How do we assess the benefit to risk of these potentially novel therapies?

Journal: Osteoarthritis and cartilage open

Published: November 11, 2024

Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.

Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set.

Journal: Seminars in arthritis and rheumatism

Published: November 07, 2024

Long-Term Exposure to Outdoor Ultrafine Particles and Black Carbon and Effects on Mortality in Montreal and Toronto, Canada.

Long-Term Exposure to Outdoor Ultrafine Particles and Black Carbon and Effects on Mortality in Montreal and Toronto, Canada.

Journal: Research report (Health Effects Institute)

Published: October 11, 2024

Summary of findings tables for measurement property reviews: The evolution and application of OMERACT's summary of measurement properties (SOMP) Table.

Summary of findings tables for measurement property reviews: The evolution and application of OMERACT's summary of measurement properties (SOMP) Table.

Journal: Seminars in arthritis and rheumatism

Published: August 16, 2024

Surface modification of extracellular vesicles with polyoxazolines to enhance their plasma stability and tumor accumulation.

Surface modification of extracellular vesicles with polyoxazolines to enhance their plasma stability and tumor accumulation.

Journal: Biomaterials

Published: April 26, 2024

Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development.

Fostering connections at OMERACT 2023: A collaborative approach to Core Outcome Set development.

Journal: Seminars in arthritis and rheumatism

Published: April 22, 2024

Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial.

Efficacy and safety of a diffusion-based extended-release fluticasone propionate intra-articular injection (EP-104IAR) in knee osteoarthritis (SPRINGBOARD): a 24-week, multicentre, randomised, double-blind, vehicle-controlled, phase 2 trial.

Journal: The Lancet. Rheumatology

Published: April 17, 2024

Showing 1-12 of 112

Last Updated: 09/26/2026